Five antiretroviral combinations associated with cardiovascular events

Five antiretroviral combinations associated with an increased risk of cardiovascular event

Drug therapy

Algu8ns of us, due to the long duration of treatment; I for example, we take many medications. MAs not all for HIV. My antiretroviral therapy is composed of 3 tablets once a day and that would be all, was not the last dismal with very high doses of medication in dosages that a doctor came to my last comment before me, with sadness in his eyes, 'My God , how could I do that to you? ' I redargui it was the knowledge they had and, perhaps, was not why I'm still alive, despite many pills I take, and that, according to a neurologist who comes to me, told me he can not pass me any other medicine because I'm on the verge of a "drug poisoning." I do not care!> I do not give, and it is to be alive, despite the worst predictions I received!

Treatment with four or five combinations of anti-HIV drugs is associated with an increased risk of a cardiovascular event, reported in the United States researchers online edition Clinical-Infectious Diseases.

But the authors point out that the absolute risk of an event was low and suggest "the primary consideration in the choice of ART [antiretroviral therapy], the treatment regimen should be administered considering its effectiveness for HIV and the organic tolerability.

In situations where it is available equally effective therapeutic regimens, physicians should consider the potential increased risk of cardiovascular events, particularly in patients who are older or who have cardiovascular risk factors. "

The life expectancy of many people with HIV is basically normal now (translator's note: dir would 70 years or more). However, the cardiovascular disease is a leading cause of serious illness and death among people with HIV. The reasons for this are not yet fully understood. It is believed that traditional risk factors play an important role, so the inflammatory effects of HIV infection. But the anti-HIV agents, especially abacavir and protease inhibitors, have been associated with an increased risk of a cardiovascular event in some studies.

Anti-HIV therapy consists of a treatment with a combination of at least three antiretroviral drugs. Therefore, it is important to know whether certain drug combinations can increase the risk of events cardiovascular7eg.

To answer this question, the researchers devised a study involving 24.510 people with HIV enrolled in veterans whose records showing who received antiretroviral combination therapy between the years 1996 and 2009.

"We chose to evaluate the most effective drug combinations because drugs are always used in combination," the authors explain. "It is possible that drug combinations may cardiovascular8Is in a way that could not be discovered by evaluating only individual drugs, or by evaluating drug classes, as previous studies have done. "

Fifteen specific drugs and 23 combinations were considered in the analysis of the researchers. Integrase inhibitors and the newer analogues non-nucleotide reverse transcriptase inhibitors (NNRTIs) have not been included, but older drugs, such as indinavir, nelfinavir and "full dose" ritonavir were included.

Study participants had an initial mean age of 47 years. Almost half (47%) had a history of smokingcardiovascular And 12% showed evidence of diabetes. Although less than 1% of individuals have experienced an event cardiovascular9In the baseline, about 18% have taken statins for a year or more. The authors believe that the high prevalence of risk factors cardiovascular10Made this population particularly suitable for examining the association between different antiretroviral drugs and the combinations and risk of events cardiovascular11Es - heart attack, stroke, percutaneous coronary intervention (angioplasty) and myocardial revascularization surgery.

During the 16,4 years of follow up, 934 people had an event cardiovascular12.

The study examined the relationship between current exposure of drug combinations at the time of an event rather than cumulative exposure.

Current treatment with four individual drugs was associated with this result:

  • Lamivudine (OR = 1,53, 95% IC1,34 -1.75)
  • Abacavir (OR = 1,50, 95% IC1,26 -1,79)
  • Efavirenz (OR = 1,40; IC95 1,19 -1.66%)
  • Zidovudine (OR = 1,41, 95% CI, 1.22-1 -63)

Current therapy with five therapeutic regimens was also associated with increased risk of an event cardiovascular13.

  • Abacavir / lamivudine / atazanavir (OR = 2,08; IC95 1,41 -3.06%)
  • Zidovudine / lamivudine / atazanavir (OR = 2,04, 95% IC1,37 -3,02)
  • Abacavir / lamivudine / efavirenz (OR = 1,94, 95% IC1,34 -2.79)
  • Zidovudine / lamivudine / efavirenz (OR = 1,60, 95% IC1,25 -2,04)
  • Zidovudine / abacavir / lamivudine (OR = 1,60, 95 -1,21 IC2,11%).

The authors emphasized that their tests were designed to take into account risk of competing factors. The results were similar for a secondary analysis, implying four- and two-drug combinations therapies.

"Our study is the first to assess the association between antiretroviral drug combinations and event risk cardiovascular14Es, "the researchers say. "Five combinations were implicated by our primary analysis."

But the researchers urge caution in interpreting the results.

"To provide some context for our results, we found that the absolute risk of events cardiovascular15For our cohort is twice as high as that of a population with risk factors cardiovascular16(Approximately 4% versus 1,8%). The absolute risk, however, is still low. We suggest doctors interpret our findings in light of the relatively low absolute risk of events cardiovascular17Is ".

Note from the publisher of Seropositive Web Site: It is important, in our part, as important actors in our survival, in view of these results, seek to minimize these risks cardiovascular18With exercises, even if simple and independent of a gym. There is an application, for IOS and ANDROID called CARDIOTRAINER, which makes the walking activity quite interesting! If you release the software to spend the battery and connect to a satellite it measures the distance you walked and how much has risen topographically speaking. It states, in a simplistic way, that in the exercise you have consumed, for example, the equivalent of two cherries or four apples. It's a cool way for you to compete with yourself, your biggest rival and I came on a walk of 25KM in three and a half hours, in which there was an elevation of twenty-five meters!

There is the challenge.

I want to see the picture of a walk less than this because, between us, ordinary mortals, I feel "The best "

Of course my proposal, though valid, is just one example. You can buy a bag of sand, has resources for it, put a picture of HIV and sit at beating the sandbag; care he responds yes!

Power must be balanced, light, rich in fibers etc.,

And who need spare vitamins and can not pay because the price is absurd, I point out this site (and you will purchase for your purchase risk) which is this link (Remember to consult your doctor about what u need to reset). The price is right and you will quickly conclude that rogue here care, they put their seals and sell with 400% profit. Do not automedique, ask your doctor to do a search (a blood test) to find out what you need and really need to reset. Remember that, according to the wise Drausio Dr. Varella, the Human body is designed to move and so we have so many "hinges". Binds and sends bullet

Michael Carter

Published: 08 2015 of bathing suits

Translated from English, in the original at http://www.aidsmap.com/Five-antiantitroviral-combinations-associated-with-increased-risk-of-cardiovascular19-event / page / 2964927 / by Cláudio Santos de Souza. I kindly request that you, the reader, if you have found any error or typing, or even a typo, that you contact from this link

Reference

Desai M. et al. Risk of cardiovascular20 Events associated with current exposure to HIV antiretroviral therapies in a US veteran population. Clin Infect Dis, online edition, 2015.

omostro Lake